Treatment of adult short bowel syndrome patients with teduglutide (Q37973750)

26 August 2017

title

Treatment of adult short bowel syndrome patients with teduglutide (English)

1 reference

26 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

Palle Bekker Jeppesen

series ordinal

3

0 references

Jens Juul Holst

object named as

Jens Juul Holst

series ordinal

2

0 references

author name string

Lærke Marijke Nørholk

series ordinal

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

6 January 2012

1 reference

Expert Opinion on Pharmacotherapy

26 August 2017

published in

1 reference

26 August 2017

volume

13

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

235-243

1 reference

Intestinal failure defined by measurements of intestinal energy and wet weight absorption

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Short bowel syndrome and intestinal failure: consensus definitions and overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

AGA technical review on short bowel syndrome and intestinal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

The short bowel syndrome: what's new and old?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Some new insights in intestinal failure-associated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Quality of life in patients receiving home parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

A review of the quality of life of adult patients treated with long-term parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

The influence of a preserved colon on the absorption of medium chain fat in patients with small bowel resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Oral salt supplements to compensate for jejunostomy losses: comparison of sodium chloride capsules, glucose electrolyte solution, and glucose polymer electrolyte solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Effect of codeine phosphate, Lomotil, and Isogel on iileostomy function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Improved Nutrient Absorption after Cimetidine in Short-Bowel Syndrome with Gastric Hypersecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Growth factors in short-bowel syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Home parenteral nutrition: survival, cost, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Glucagon-like peptide-2 increases mesenteric blood flow in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Enteroendocrine localization of GLP-2 receptor expression in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Modulation of specific intestinal epithelial progenitors by enteric neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Pharmacokinetics, safety, and tolerability of teduglutide, a glucagon-like peptide-2 (GLP-2) analog, following multiple ascending subcutaneous administrations in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

Four-month treatment with GLP-2 significantly increases hip BMD

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.644787

10.1517/14656566.2012.644787

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference